Sign In
Buy HIMS
$27.77
+0.730 (+2.70%)
At Close: Jul 31, 2026
Wall Street Breakfast Podcast: Trump Targets Pump Prices
06:56am, Tuesday, 12'th May 2026
Hims & Hers Health (HIMS) drops ~14% as Q1 results miss on both revenue and EPS, with US revenue down 8% year-over-year. Monthly revenue per average HIMS subscriber declined 6% YoY to $80, though tota
Hims & Hers plunges after weight-loss pivot hits quarterly results
06:12am, Tuesday, 12'th May 2026
Shares of Hims & Hers Health fell 15% premarket on Tuesday after the telehealth company missed Wall Street estimates for first-quarter revenue and posted a surprise loss, hurt by changes in its
Hims & Hers Health, Inc. (HIMS) Q1 2026 Earnings Call Transcript
04:50am, Tuesday, 12'th May 2026
Hims & Hers Health, Inc. (HIMS) Q1 2026 Earnings Call Transcript
Hims & Hers Health Q1 Earnings Call Highlights
12:07am, Tuesday, 12'th May 2026
Hims & Hers Health NYSE: HIMS reported first-quarter 2026 revenue growth and raised its full-year revenue outlook, while executives said a strategic shift in the company's weight-loss business is crea
Hims & Hers Health: Mixed Q1 2026 Is Not A Thesis Breaker
07:52pm, Monday, 11'th May 2026
Hims & Hers Health, Inc. remains a Buy, with a solid bottom forming despite recent margin and revenue challenges. HIMS is pivoting from compounded GLP-1s to branded partnerships with NVO and LLY, impa
Hims & Hers Health, Inc. (HIMS) Reports Q1 Loss, Misses Revenue Estimates
06:25pm, Monday, 11'th May 2026
Hims & Hers Health, Inc. (HIMS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of $0.04. This compares to earnings of $0.2 per share a year ago.
Hims & Hers Health Swings to First-Quarter Loss as Expenses Rise
05:06pm, Monday, 11'th May 2026
The telehealth platform posted a quarterly loss of $92.1 million, offsetting a 4% increase in revenue.
Why Hims & Hers Health Are Falling Monday
04:34pm, Monday, 11'th May 2026
Hims & Hers Health reported first-quarter financial results Monday after market close.
Hims & Hers Stock Sinks. Why Earnings Offered Wall Street A Big Surprise.
04:30pm, Monday, 11'th May 2026
Hims & Hers shares are falling after reporting disappointing first-quarter earnings results.
Hims & Hers raises 2026 revenue forecast on strong demand for personalized care
04:11pm, Monday, 11'th May 2026
Hims & Hers Health raised its 2026 revenue forecast on Monday, betting on increased sales for its personalized healthcare offerings.
Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
04:05pm, Monday, 11'th May 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first
Live: Hims Reports Q1 Earnings Tonight. Can the Recovery Continue?
02:40pm, Monday, 11'th May 2026
Live Updates The analyst who called NVIDIA in 2010 just named his top 10 AI stocksThis analyst's 2025 picks are up 106% on average. He just named his top 10 stocks to buy in 2026. Get them here FREE.
Hims & Hers Expands Digital Healthcare Platform via New Care Offerings
12:47pm, Monday, 11'th May 2026
HIMS broadens its digital health platform with Labs, menopause and testosterone care, global acquisitions and a Novo Nordisk GLP-1 tie-up.
Can Platform Expansion Support Hims & Hers Stock Before Q1 Earnings?
02:01pm, Friday, 08'th May 2026
HIMS first-quarter 2026 results are likely to benefit from Labs and branded weight loss medications even as higher costs and GLP-1 scrutiny linger.
Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus
11:11am, Friday, 08'th May 2026
Healthcare stocks have struggled in 2026. With a year-to-date (YTD) loss of about 6%, that corner of the market has been the worst performer among all 11 sectors of the S&P 500 in 2026.
